These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 3072894)

  • 21. Enalapril and atenolol in primary hypertension--a comparative study of blood pressure lowering and hormonal effects.
    Ohman KP; Karlberg BE
    Scand J Urol Nephrol Suppl; 1984; 79():93-7. PubMed ID: 6089325
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nitrendipine and atenolol: comparison and combination in the treatment of arterial hypertension.
    de Divitiis O; Petitto M; Di Somma S; Galderisi M; Villari B; Santomauro M; Fazio S
    Arzneimittelforschung; 1985; 35(4):727-9. PubMed ID: 3160356
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and safety comparative evaluation of orlistat and sibutramine treatment in hypertensive obese patients.
    Derosa G; Cicero AF; Murdolo G; Piccinni MN; Fogari E; Bertone G; Ciccarelli L; Fogari R
    Diabetes Obes Metab; 2005 Jan; 7(1):47-55. PubMed ID: 15642075
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of bisoprolol and acebutolol on resting blood pressure and on exercise blood pressure profile in hypertensive patients: a comparative, single-blind study.
    Bouvier JM; Rabot D; Herrero G
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S179-83. PubMed ID: 11527124
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changes in blood pressure, heart rate and thyroid hormones after sudden withdrawal of pindolol and atenolol in hypertensive patients.
    Jespersen CM; Jørgensen PH; Krogsgaard AR; Friis T
    Scand J Clin Lab Invest; 1986 Nov; 46(7):615-21. PubMed ID: 3538363
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sibutramine is safe and effective for weight loss in obese patients whose hypertension is well controlled with angiotensin-converting enzyme inhibitors.
    McMahon FG; Weinstein SP; Rowe E; Ernst KR; Johnson F; Fujioka K;
    J Hum Hypertens; 2002 Jan; 16(1):5-11. PubMed ID: 11840224
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolic outcome during 1 year in newly detected hypertensives: results of the Antihypertensive Treatment and Lipid Profile in a North of Sweden Efficacy Evaluation (ALPINE study).
    Lindholm LH; Persson M; Alaupovic P; Carlberg B; Svensson A; Samuelsson O
    J Hypertens; 2003 Aug; 21(8):1563-74. PubMed ID: 12872052
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Catecholamines and heart function in heart transplant patients: effects of beta1- versus nonselective beta-blockade.
    Leenen FH; Davies RA; Fourney A
    Clin Pharmacol Ther; 1998 Nov; 64(5):522-35. PubMed ID: 9834044
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative effects of atenolol versus nifedipine on serum lipids and other biochemical parameters in diabetic and non-diabetic hypertensive subjects.
    Satia MC; Shukla ML; Goyal RK
    Indian J Physiol Pharmacol; 1995 Jul; 39(3):237-41. PubMed ID: 8550116
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Blood pressure reactivity in the evaluation of resting blood pressure and mood responses to pindolol and propranolol in hypertensive patients.
    Potempa KM; Fogg LF; Fish AF; Kravitz HM
    Heart Lung; 1993; 22(5):383-91. PubMed ID: 8226001
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of ketanserin and pindolol in hypertension.
    Gordin A; Saraste K; Turanlahti M; Sundberg S
    J Hypertens Suppl; 1986 Apr; 4(1):S61-2. PubMed ID: 2939214
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Placebo-controlled comparison of captopril, atenolol, labetalol, and pindolol in hypertension complicated by intermittent claudication.
    Roberts DH; Tsao Y; McLoughlin GA; Breckenridge A
    Lancet; 1987 Sep; 2(8560):650-3. PubMed ID: 2887941
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Double-blind comparison of once-daily bopindolol, pindolol and atenolol in essential hypertension.
    Schiess W; Welzel D; Gugler R
    Eur J Clin Pharmacol; 1984; 27(5):529-34. PubMed ID: 6151506
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparison of atenolol and long-acting trimazosin in mild to moderate essential hypertension.
    Webb DJ; Hutcheson MJ; Robertson MP; Murray GD; Lorimer AR; Robertson JI
    Scott Med J; 1985 Apr; 30(2):106-10. PubMed ID: 3892676
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of the metabolic effects of long-term treatment with pindolol or atenolol by hypertensive patients.
    Lehtonen A
    Cardiovasc Drugs Ther; 1988 Jan; 1(5):549-51. PubMed ID: 3154682
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pindolol in hypertension: twice-daily versus thrice-daily dosage.
    Waal-Manning HJ; Wood AJ
    Med J Aust; 1975 Aug; 2(7):274-5. PubMed ID: 1160793
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of pindolol versus atenolol on lipid profile in hypertensive patients.
    Notghi A; Riemersma RA; Anderton JL; Oliver MF
    Atherosclerosis; 1989 Jun; 77(2-3):215-20. PubMed ID: 2751753
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Randomised controlled trial of atenolol and pindolol in human pregnancy: effects on fetal haemodynamics.
    Montan S; Ingemarsson I; Marsál K; Sjöberg NO
    BMJ; 1992 Apr; 304(6832):946-9. PubMed ID: 1581716
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Beta adrenoreceptor-blocking drugs once daily in essential hypertension: a comparison of propranolol, pindolol and atenolol.
    England JD
    Aust N Z J Med; 1981 Feb; 11(1):35-40. PubMed ID: 7018482
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The influence of pindolol and hydrochlorothiazide on blood pressure, and plasma renin and plasma lipid levels.
    Johnson BF; Weiner B; Marwaha R; Johnson J
    J Clin Pharmacol; 1986 Apr; 26(4):258-63. PubMed ID: 3517076
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.